Clinical Trial

Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

Name: Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer — clinical trial record (NCT07419932)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NeoLATC

Recruiting

View on ClinicalTrials.gov →

Summary

This multicenter observational study aims to evaluate the safety and efficacy of neoadjuvant therapy in patients with locally advanced thyroid cancer, focusing on imaging, biochemical, and pathological responses, as well as short-term surgical outcomes and long-term prognosis.

Trial Details

NCT Number	NCT07419932
Lead Sponsor	Fujian Medical University
Conditions	Thyroid Cancer, Thyroid Neoplasms
Enrollment	120 participants
Start Date	2025-12-23
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-19